BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29772545)

  • 21. Muscarinic type 3 receptor autoantibodies are associated with anti-SSA/Ro autoantibodies in Sjögren's syndrome.
    Zuo J; Williams AE; Park YJ; Choi K; Chan AL; Reeves WH; Bubb MR; Lee YJ; Park K; Stewart CM; Cha S
    J Immunol Methods; 2016 Oct; 437():28-36. PubMed ID: 27460476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjogren's syndrome patients.
    Koo NY; Li J; Hwang SM; Choi SY; Lee SJ; Oh SB; Kim JS; Lee EB; Song YW; Park K
    Rheumatology (Oxford); 2008 Jun; 47(6):828-33. PubMed ID: 18400835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel cell-based assay for inhibitory anti-muscarinic type 3 receptor antibodies in primary Sjögren's syndrome.
    Bastian I; Gordon TP; Jackson MW
    J Immunol Methods; 2015 Dec; 427():117-21. PubMed ID: 26584897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mimotope mimicking epidermal growth factor receptor alleviates mononuclear cell infiltration in exocrine glands induced by muscarinic acetylcholine 3 receptor.
    Yang L; Wang Y; Xing R; Bai L; Li C; Li Z; Liu X
    Clin Immunol; 2016 Feb; 163():111-9. PubMed ID: 26794912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation and functional analysis of monoclonal antibodies against the second extracellular loop of human M3 muscarinic acetylcholine receptor.
    Tsuboi H; Nakamura Y; Iizuka M; Matsuo N; Matsumoto I; Sumida T
    Mod Rheumatol; 2012 Apr; 22(2):264-71. PubMed ID: 21877253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The anergy induction of M3 muscarinic acetylcholine receptor-reactive CD4+ T cells suppresses experimental sialadenitis-like Sjögren's syndrome.
    Asashima H; Tsuboi H; Takahashi H; Hirota T; Iizuka M; Kondo Y; Matsui M; Matsumoto I; Sumida T
    Arthritis Rheumatol; 2015 May; 67(8):2213-25. PubMed ID: 25891013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Passive transfer of Sjogren's syndrome IgG produces the pathophysiology of overactive bladder.
    Wang F; Jackson MW; Maughan V; Cavill D; Smith AJ; Waterman SA; Gordon TP
    Arthritis Rheum; 2004 Nov; 50(11):3637-45. PubMed ID: 15529387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells.
    Dawson LJ; Stanbury J; Venn N; Hasdimir B; Rogers SN; Smith PM
    Arthritis Rheum; 2006 Apr; 54(4):1165-73. PubMed ID: 16572451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Antimuscarinic Autoantibodies in Primary Sjögren's Syndrome.
    Kim N; Shin Y; Choi S; Namkoong E; Kim M; Lee J; Song Y; Park K
    J Dent Res; 2015 May; 94(5):722-8. PubMed ID: 25784251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of anti-muscarinic receptor type 3 antibodies for the diagnosis of Sjögren syndrome.
    Deng C; Hu C; Chen S; Li J; Wen X; Wu Z; Li Y; Zhang F; Li Y
    PLoS One; 2015; 10(1):e0116744. PubMed ID: 25629973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis.
    Tahara M; Tsuboi H; Segawa S; Asashima H; Iizuka-Koga M; Hirota T; Takahashi H; Kondo Y; Matsui M; Matsumoto I; Sumida T
    Clin Exp Immunol; 2017 Feb; 187(2):213-224. PubMed ID: 27643385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Younger patients with primary Sjögren's syndrome are more likely to have salivary IgG anti-muscarinic acetylcholine receptor type 3 antibodies.
    Jayakanthan K; Ramya J; Mandal SK; Sandhya P; Gowri M; Danda D
    Clin Rheumatol; 2016 Mar; 35(3):657-62. PubMed ID: 26809799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutralization of muscarinic receptor autoantibodies by intravenous immunoglobulin in Sjögren syndrome.
    Smith AJ; Jackson MW; Wang F; Cavill D; Rischmueller M; Gordon TP
    Hum Immunol; 2005 Apr; 66(4):411-6. PubMed ID: 15866705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptide-based ELISAs are not sensitive and specific enough to detect muscarinic receptor type 3 autoantibodies in serum from patients with Sjogren's syndrome.
    Roescher N; Kingman A; Shirota Y; Chiorini JA; Illei GG
    Ann Rheum Dis; 2011 Jan; 70(1):235-6. PubMed ID: 20498204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome.
    Waterman SA; Gordon TP; Rischmueller M
    Arthritis Rheum; 2000 Jul; 43(7):1647-54. PubMed ID: 10902771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transgenic rice seeds expressing altered peptide ligands against the M3 muscarinic acetylcholine receptor suppress experimental sialadenitis-like Sjögren's syndrome.
    Kudo H; Tsuboi H; Asashima H; Takahashi H; Ono Y; Abe S; Honda F; Kondo Y; Wakasa Y; Takaiwa F; Takano M; Matsui M; Matsumoto I; Sumida T
    Mod Rheumatol; 2020 Sep; 30(5):884-893. PubMed ID: 31490711
    [No Abstract]   [Full Text] [Related]  

  • 37. Mechanism of cAMP-PKA Signaling Pathway Mediated by Shaoyao Gancao Decoction () on Regulation of Aquaporin 5 and Muscarinic Receptor 3 Levels in Sjögren's Syndrome.
    Wang D; Zhao H; Li B; Sun Y; Wei DH
    Chin J Integr Med; 2020 Jul; 26(7):502-509. PubMed ID: 32632716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in Sjögren's syndrome.
    Park K; Haberberger RV; Gordon TP; Jackson MW
    Arthritis Rheum; 2011 May; 63(5):1426-34. PubMed ID: 21312189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are autoantibodies against a 25-mer synthetic peptide of M3 muscarinic acetylcholine receptor a new diagnostic marker for Sjögren's syndrome?
    Zigon P; Bozic B; Cucnik S; Rozman B; Tomsic M; Kveder T
    Ann Rheum Dis; 2005 Aug; 64(8):1247; author reply 1247. PubMed ID: 16014696
    [No Abstract]   [Full Text] [Related]  

  • 40. Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjogren's syndrome using conventional immunological approaches.
    Dawson LJ; Allison HE; Stanbury J; Fitzgerald D; Smith PM
    Rheumatology (Oxford); 2004 Dec; 43(12):1488-95. PubMed ID: 15353609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.